12-120999579-A-G

Variant summary

Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP5BA1

This summary comes from the ClinGen Evidence Repository: The c.1720A>G variant in the HNF1 homeobox A gene, HNF1A, causes an amino acid change of serine to glycine at codon 574 (p.(Ser574Gly)) of NM_000545.8. This variant has a Popmax Filtering allele frequency in gnomAD 2.1.1 of 0.996; however, given that the G (Gly) alternate allele has frequencies ≥95% in all subpopulations, we have recalculated the Popmax Filtering allele frequency based on the highest prevalence of the A (Ser) reference allele being found in the African/African-American subpopulation (1144/24164 = 0.0473). The newly calculated Popmax Filtering allele frequency is 0.0447, which is greater than the MDEP threshold for BA1 (≥0.0001) (BA1). Additionally, this variant was identified in a patient with an alternate molecular basis for disease (BP5; internal lab contributors). In summary, c.1720A>G meets the criteria to be classified as benign for monogenic diabetes. ACMG/AMP criteria applied, as specified by the ClinGen MDEP (specification version 1.1, approved 9/30/2021): BA1, BP5. LINK:https://erepo.genome.network/evrepo/ui/classification/CA214285/MONDO:0015967/017

Frequency

Genomes: 𝑓 0.99 ( 74262 hom., cov: 32)
Exomes 𝑓: 1.0 ( 728232 hom. )

Consequence

HNF1A
NM_000545.8 missense

Scores

1
16

Clinical Significance

Benign reviewed by expert panel P:3B:8O:2

Conservation

PhyloP100: 0.738
Variant links:
Genes affected
HNF1A (HGNC:11621): (HNF1 homeobox A) The protein encoded by this gene is a transcription factor required for the expression of several liver-specific genes. The encoded protein functions as a homodimer and binds to the inverted palindrome 5'-GTTAATNATTAAC-3'. Defects in this gene are a cause of maturity onset diabetes of the young type 3 (MODY3) and also can result in the appearance of hepatic adenomas. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Apr 2015]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -9 ACMG points.

BP5
For more information check the summary or visit ClinGen Evidence Repository.
BA1
For more information check the summary or visit ClinGen Evidence Repository.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
HNF1ANM_000545.8 linkuse as main transcriptc.1720A>G p.Ser574Gly missense_variant 9/10 ENST00000257555.11 NP_000536.6 P20823E0YMI7
HNF1ANM_001306179.2 linkuse as main transcriptc.1741A>G p.Ser581Gly missense_variant 9/10 NP_001293108.2 P20823E0YMI7
HNF1ANM_001406915.1 linkuse as main transcriptc.1528A>G p.Ser510Gly missense_variant 8/9 NP_001393844.1
HNF1AXM_024449168.2 linkuse as main transcriptc.1813A>G p.Ser605Gly missense_variant 8/9 XP_024304936.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
HNF1AENST00000257555.11 linkuse as main transcriptc.1720A>G p.Ser574Gly missense_variant 9/101 NM_000545.8 ENSP00000257555.5 A0A0A0MQU7

Frequencies

GnomAD3 genomes
AF:
0.987
AC:
150280
AN:
152240
Hom.:
74204
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.955
Gnomad AMI
AF:
1.00
Gnomad AMR
AF:
0.995
Gnomad ASJ
AF:
1.00
Gnomad EAS
AF:
1.00
Gnomad SAS
AF:
1.00
Gnomad FIN
AF:
1.00
Gnomad MID
AF:
1.00
Gnomad NFE
AF:
1.00
Gnomad OTH
AF:
0.990
GnomAD3 exomes
AF:
0.996
AC:
242441
AN:
243302
Hom.:
120811
AF XY:
0.997
AC XY:
132201
AN XY:
132560
show subpopulations
Gnomad AFR exome
AF:
0.952
Gnomad AMR exome
AF:
0.998
Gnomad ASJ exome
AF:
1.00
Gnomad EAS exome
AF:
1.00
Gnomad SAS exome
AF:
1.00
Gnomad FIN exome
AF:
1.00
Gnomad NFE exome
AF:
1.00
Gnomad OTH exome
AF:
0.999
GnomAD4 exome
AF:
0.999
AC:
1458380
AN:
1460398
Hom.:
728232
Cov.:
56
AF XY:
0.999
AC XY:
725656
AN XY:
726522
show subpopulations
Gnomad4 AFR exome
AF:
0.953
Gnomad4 AMR exome
AF:
0.997
Gnomad4 ASJ exome
AF:
1.00
Gnomad4 EAS exome
AF:
1.00
Gnomad4 SAS exome
AF:
1.00
Gnomad4 FIN exome
AF:
1.00
Gnomad4 NFE exome
AF:
1.00
Gnomad4 OTH exome
AF:
0.997
GnomAD4 genome
AF:
0.987
AC:
150397
AN:
152358
Hom.:
74262
Cov.:
32
AF XY:
0.988
AC XY:
73612
AN XY:
74498
show subpopulations
Gnomad4 AFR
AF:
0.955
Gnomad4 AMR
AF:
0.995
Gnomad4 ASJ
AF:
1.00
Gnomad4 EAS
AF:
1.00
Gnomad4 SAS
AF:
1.00
Gnomad4 FIN
AF:
1.00
Gnomad4 NFE
AF:
1.00
Gnomad4 OTH
AF:
0.991
Alfa
AF:
0.993
Hom.:
36535
Bravo
AF:
0.985
TwinsUK
AF:
1.00
AC:
3708
ALSPAC
AF:
1.00
AC:
3853
ESP6500AA
AF:
0.962
AC:
4219
ESP6500EA
AF:
1.00
AC:
8575
ExAC
AF:
0.996
AC:
120540
Asia WGS
AF:
0.999
AC:
3473
AN:
3478
EpiCase
AF:
1.00
EpiControl
AF:
1.00

ClinVar

Significance: Benign
Submissions summary: Pathogenic:3Benign:8Other:2
Revision: reviewed by expert panel
LINK: link

Submissions by phenotype

not provided Benign:3
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpFeb 01, 2024- -
Benign, criteria provided, single submitterclinical testingARUP Laboratories, Molecular Genetics and Genomics, ARUP LaboratoriesNov 29, 2023- -
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
not specified Benign:1Other:1
Benign, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineSep 10, 2018This variant represents a RefSeq error. The hg19 reference base (c.1720A) is the minor allele. This allele (A) has been identified in 4.71% (1098/23336) of Afri can chromosomes in gnomAD (http://gnomad.broadinstitute.org) and thus meets crit eria to be classified as benign. -
not provided, no classification providedreference populationITMISep 19, 2013- -
Maturity-onset diabetes of the young type 3 Benign:1Other:1
not provided, no classification providedclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpAug 18, 2011- -
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabAug 10, 2021- -
Reduced delayed hypersensitivity Pathogenic:1
Likely pathogenic, no assertion criteria providedclinical testingPhenosystems SA-- -
Symphalangism affecting the proximal phalanx of the 4th finger Pathogenic:1
Likely pathogenic, no assertion criteria providedclinical testingPhenosystems SA-- -
Breast carcinoma Pathogenic:1
Likely pathogenic, no assertion criteria providedclinical testingPhenosystems SA-- -
Diabetes mellitus type 1;C0011860:Type 2 diabetes mellitus;C1838100:Maturity-onset diabetes of the young type 3;C1840646:Hepatic adenomas, familial;C2675866:Type 1 diabetes mellitus 20;CN074294:Nonpapillary renal cell carcinoma Benign:1
Benign, criteria provided, single submitterclinical testingFulgent Genetics, Fulgent GeneticsSep 13, 2021- -
Maturity onset diabetes mellitus in young Benign:1
Benign, criteria provided, single submitterresearchClinical Genomics, Uppaluri K&H Personalized Medicine Clinic-Mutations in HNF1A gene can predispose to MODY3. It is associated with both micro and macrovascular complications of diabetes, especially cardiovascular complications. Associated with glucosuria. May respond well to sulfonylureas. Sufficient evidence is found to confer the association of this particular variant rs1169305 with MODY3. -
Monogenic diabetes Benign:1
Benign, reviewed by expert panelcurationClinGen Monogenic Diabetes Variant Curation Expert PanelApr 18, 2022The c.1720A>G variant in the HNF1 homeobox A gene, HNF1A, causes an amino acid change of serine to glycine at codon 574 (p.(Ser574Gly)) of NM_000545.8. This variant has a Popmax Filtering allele frequency in gnomAD 2.1.1 of 0.996; however, given that the G (Gly) alternate allele has frequencies greater than or equal to95% in all subpopulations, we have recalculated the Popmax Filtering allele frequency based on the highest prevalence of the A (Ser) reference allele being found in the African/African-American subpopulation (1144/24164 = 0.0473). The newly calculated Popmax Filtering allele frequency is 0.0447, which is greater than the MDEP threshold for BA1 (greater than or equal to 0.0001) (BA1). Additionally, this variant was identified in a patient with an alternate molecular basis for disease (BP5; internal lab contributors). In summary, c.1720A>G meets the criteria to be classified as benign for monogenic diabetes. ACMG/AMP criteria applied, as specified by the ClinGen MDEP (specification version 1.1, approved 9/30/2021): BA1, BP5. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.051
BayesDel_addAF
Benign
-0.34
T
BayesDel_noAF
Benign
-0.23
CADD
Benign
7.1
DANN
Benign
0.72
DEOGEN2
Uncertain
0.42
.;T;.;T;.
Eigen
Benign
-0.94
Eigen_PC
Benign
-0.90
FATHMM_MKL
Benign
0.010
N
LIST_S2
Benign
0.040
T;T;T;T;T
MetaRNN
Benign
7.1e-7
T;T;T;T;T
MetaSVM
Benign
-0.95
T
PrimateAI
Benign
0.41
T
PROVEAN
Benign
-0.080
N;.;.;N;N
REVEL
Benign
0.16
Sift
Benign
0.78
T;.;.;T;T
Sift4G
Benign
0.51
T;T;T;T;T
Polyphen
0.0
.;.;.;.;B
Vest4
0.080
MPC
0.11
ClinPred
0.00068
T
GERP RS
2.6
gMVP
0.37

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs1169305; hg19: chr12-121437382; COSMIC: COSV56568164; COSMIC: COSV56568164; API